GlobeNewswire

Cisco Brings Visibility and Insights to IT's Biggest Blind Spot: The WAN

Dela
  • Cisco delivers intent-based networking for the wide area network (WAN) with new analytics and assurance solutions.
  • Cisco solutions provide the visibility and insight that allow customers to quickly isolate and resolve issues in the WAN.
  • Cisco solutions provide deep learning capabilities that can predict issues before they happen, potentially saving organizations from experiencing costly downtime.

MELBOURNE, Australia, March 07, 2018 (GLOBE NEWSWIRE) -- Cisco today announced new innovations built to bring visibility to IT's biggest blind spot: the wide-area network (WAN). Made up of disparate networks outside of the control of IT, the WAN connects employees to applications, no matter where those employees might be. The fragmented nature of the WAN means that IT often has limited ability to specifically determine problems and get real-time information. Now, Cisco is helping IT by providing the capability to forecast WAN problems before they happen, while quickly isolating and fixing issues when they do occur.

Over the past few years, the rise of multicloud IT environments has exacerbated the traditional complexity of the WAN and magnified its challenges. A recent IDC study (Worldwide SD-WAN Survey Special Report September 2017) discovered that almost 3 out of 10 organizations considered network outages to be a top WAN concern, with the same number stating they need better visibility and analytics to manage application and WAN performance.

Building on the company's recent push toward intent-based networking, Cisco is driving this network revolution to the WAN. Today, Cisco is introducing innovations to provide IT with the vital visibility and insight into the WAN that will help keep businesses up and running:

  • Cisco® SD-WAN vAnalytics provide IT with visibility, forecasting for applications and bandwidth planning, "what-if" scenarios, and actionable recommendations.
  • Cisco Meraki(TM) Insight helps IT administrators optimize the end user experience by providing valuable understanding into WAN and SaaS application performance, significantly reducing the time it takes to isolate and resolve issues.

"We have set an ambitious goal for ourselves of transforming the entire network, from campus to branch, data center to edge," said Scott Harrell, senior vice president and general manager, Enterprise Networking at Cisco. "The WAN is a vital part of the network and is one of the toughest to manage. As we bring insight into the WAN with these new innovations, we get closer to delivering end-to-end intent-based networking to help our customers eliminate downtime and save money."

Cisco provides a full portfolio of services to help accelerate a customer's journey to intent-based networking for the WAN. Services experts help customers create a customized roadmap for success, speed deployment, and maximize network performance.

Cisco SD-WAN vAnalytics 
Today, Cisco is introducing Cisco SD-WAN vAnalytics (based on Viptela® technology). Built as a cloud-based SaaS solution, the technology provides comprehensive data, analysis, and corrective actions across the WAN, including branch offices, multicloud endpoints, and multiple service providers. Using vAnalytics, customers can forecast how potential policy changes to the WAN could affect application performance. It can also provide intelligent recommendations about how to deliver optimal application experiences. For example, with vAnalytics, organizations can now better understand how a rollout of IP-enabled security cameras or a cloud-based application across multiple branch offices could affect WAN infrastructure. vAnalytics can help enterprises identify the stress points and necessary policy changes, helping customers avoid technology growing pains.

"With over 600 branch offices and more than 5,000 employees, we rely on cloud applications and an always connected workplace to serve our customers," said Peter Castle, senior network engineer, Reece Ltd. "Our business requires a secure, scalable, and high-performance WAN. With vManage, we can centrally deploy branch applications and services rapidly, and we have been able to dramatically improve branch availability and bandwidth utilization with the rich analytics this platform provides. We are looking forward to the additional functionality we will be able to achieve with the even richer application visibility that vAnalytics will provide us."

Cisco Meraki Insight
Today, Cisco Meraki is also announcing Meraki Insight, a new tool integrated into the Meraki dashboard to help IT maintain a better end-user experience. The solution provides end-to-end visibility with application and WAN performance analytics. With Meraki Insight, customers can understand and troubleshoot both internal and external issues that can contribute to poor user experience for applications hosted in a remote data center or in the cloud. Meraki Insight helps IT achieve faster time to resolution for performance issues by more accurately pinpointing the source of the problem.

"At Extra Space Storage, as we move more and more of our business-critical applications to the cloud, it is imperative to maintain a high-performance network," said Jacob Stimpson, senior analyst, IT Business at Extra Space Storage. "Meraki Insight gives us the network and SaaS application visibility we need to quickly remediate issues and ensure a great end-user experience."

Availability

  • Cisco SD-WAN vAnalytics is available now via a Cisco SD-WAN license tier.
  • Cisco Meraki Insight is expected to be available in Cisco's Q3. It will be available as a separate license.

Additional Resources

About Cisco
Cisco (NASDAQ:CSCO) is the worldwide technology leader that has been making the Internet work since 1984. Our people, products, and partners help society securely connect and seize tomorrow's digital opportunity today. Discover more at newsroom.cisco.com and follow us on Twitter at @Cisco.

Cisco and the Cisco logo are trademarks or registered trademarks of Cisco and/or its affiliates in the United States and certain other countries. A listing of Cisco's trademarks can be found at  www.cisco.com/go/trademarks .  All other trademarks mentioned are the property of their respective owners. The use of the word partner does not imply a partnership relationship between Cisco and any other company. Many of the products and features described herein remain in varying stages of development and will be offered on a when-and-if-available basis. This roadmap is subject to change at the sole discretion of Cisco, and Cisco will have no liability for delay in the delivery or failure to deliver any of the products or features set forth in this document. This document is Cisco Public Information.

Contact:

Taylor Hassman
Phone Number: 415-610-6075
Email: thassman@cisco.com

 




This announcement is distributed by Nasdaq Corporate Solutions on behalf of Nasdaq Corporate Solutions clients.
The issuer of this announcement warrants that they are solely responsible for the content, accuracy and originality of the information contained therein.
Source: Cisco via Globenewswire

Om

GlobeNewswire



Följ GlobeNewswire

Abonnera på våra pressmeddelanden.

Senaste pressmeddelandena från GlobeNewswire

Iconovo: kundprojekt blir framflyttat tre till sex månader8.11.2018 15:45Pressmeddelande

Fortsatt arbete med ett av Iconovos pågående kundprojekt kommer att flyttas fram tre till sex månader. Projektet avser utveckling av produkt anpassad för kund som ska svara för produktion och marknadslansering. Det aktuella arbetet var planerat att ske under fjärde kvartalet men beräknas ske under nästa år, och detta påverkar Iconovos omsättning under 2018 negativt med cirka 2 miljoner kronor. Orsaken är att kunden har beslutat att genomföra en mindre klinisk studie för att verifiera produkten innan nästa steg tas vilken omfattar investeringar i betydande mångmiljonbelopp i produktionskapacitet, baserat på Iconovos utveckling. Studien görs för kundens egna räkning och är inte villkorad av tillsynsmyndigheter. "Detta påverkar vårt resultat på kort sikt, men det faktum att kunden har beslutat att göra en betydande investering i faktisk produktion betyder att vi med stor säkerhet kan se fram emot licensintäkter under en lång tidsrymd framöver i samband med att produkten lanseras på markna

Stillfront Group AB: Inbjudan till Stillfront Groups kvartalsrapport för tredje kvartalet 20187.11.2018 14:34Pressmeddelande

PRESSMEDDELANDE 7 november 2018 Inbjudan till Stillfront Groups kvartalsrapport för tredje kvartalet 2018 Stillfront Groups kvartalsrapport för det tredje kvartalet 2018 kommer att publiceras klockan 07.00 den 22 november 2018. En webbsänd telefonkonferens kommer att hållas klockan 10.00 samma dag där Jörgen Larsson, VD och Sten Wranne, CFO, kommenterar resultatet. Presentationen och rapporten kommer efter presentationen att finnas tillgänglig på www.stillfront.com Webbsändningen nås på adressen: https://tv.streamfabriken.com/stillfront-q3-2018 För att delta via telefon, vänligen ring: SE: +46 8 566 426 63 UK: +44 20 300 898 01 US: +1 8 557 532 235 FÖR YTTERLIGARE INFORMATION, VÄNLIGEN KONTAKTA: Sofia Wretman, IR Phone: +46 708 11 64 30 sofia@stillfront.com OM STILLFRONT Stillfront är en oberoende utvecklare, förläggare och distributör av digitala spel - med visionen att bli en ledande indie-spelutvecklare och förläggare. Stillfront är verksamt genom tio näst intill självständiga dotte

Stillfront Group AB: Invitation to Stillfront Group Q3 presentation7.11.2018 14:34Pressmeddelande

Invitation to Stillfront Group Q3 presentation Stillfront Group interim report for the third quarter 2018 will be published at 07.00 CET on 22 November 2018. A presentation of the report will be held the same day at 10.00 CET via telephone conference or audiocast where Jörgen Larsson, CEO and CFO Sten Wranne are to comment on the report. The presentation can be viewed live at https://tv.streamfabriken.com/stillfront-q3-2018 To participate via phone please call: SE: +46 8 566 426 63 UK: +44 20 300 898 01 US: +1 8 557 532 235 FOR FURTHER INFORMATION, PLEASE CONTACT: Sofia Wretman, IR Phone: +46 708 11 64 30 sofia@stillfront.com ABOUT STILLFRONT Stillfront is a group of independent creators, publishers and distributors of digital games - with a vision to become the leading group of indie game creators and publishers. Stillfront operates through ten near-autonomous subsidiaries: Bytro Labs in Germany, Coldwood Interactive in Sweden, Power Challenge in the UK and Sweden, Dorado Online Games

Modus Therapeutics announces FDA Acceptance of Sevuparin IND for the treatment of sickle cell disease7.11.2018 08:30Pressmeddelande

STOCKHOLM, November 7, 2018. Karolinska Development's portfolio company Modus Therapeutics announces today that the U.S Food & Drug Administration (FDA) has approved the company's Investigational New Drug (IND) application to initiate a Phase I clinical trial with subcutaneous sevuparin for the treatment of sickle cell disease (SCD) FDA has decided to accept Modus Therapeutics' IND application of sevuparin for the treatment of SCD. Sevuparin is an innovative, proprietary modified polysaccharide drug with anti-adhesive, anti-aggregate and anti-inflammatory effects due to its multimodal mechanism of action. It has the potential to restore blood flow and prevent further microvascular obstructions in children and adults with SCD. At present, sevuparin is being evaluated as an intravenous infusion in a Phase II study in SCD patients with ongoing painful crises (also called vaso occlusive crises, VOC). In order to broaden the clinical scope and utility of sevuparin in the treatment of SCD, t

Modus Therapeutics announces FDA Acceptance of Sevuparin IND for the treatment of sickle cell disease7.11.2018 08:30Pressmeddelande

STOCKHOLM, November 7, 2018. Karolinska Development's portfolio company Modus Therapeutics announces today that the U.S Food & Drug Administration (FDA) has approved the company's Investigational New Drug (IND) application to initiate a Phase I clinical trial with subcutaneous sevuparin for the treatment of sickle cell disease (SCD) FDA has decided to accept Modus Therapeutics' IND application of sevuparin for the treatment of SCD. Sevuparin is an innovative, proprietary modified polysaccharide drug with anti-adhesive, anti-aggregate and anti-inflammatory effects due to its multimodal mechanism of action. It has the potential to restore blood flow and prevent further microvascular obstructions in children and adults with SCD. At present, sevuparin is being evaluated as an intravenous infusion in a Phase II study in SCD patients with ongoing painful crises (also called vaso occlusive crises, VOC). In order to broaden the clinical scope and utility of sevuparin in the treatment of SCD, t

Oboya participates in China International Import Expo1.11.2018 15:00Pressmeddelande

Newsletter Lerum, 1th November 2018 Oboya Horticulture Industries AB (publ) ("Oboya"), a global manufacturer and supplier of products and services for the cultivation industry, will participate in China International Import Expo in Shanghai, China. China International Import Expo (CIIE) is a six-day fair held from November 5 to November 10, 2018 at the National Convention & Exhibition Center in Shanghai, China. This fair brings together companies, exhibitors and professional buyers from all over the world. The fair creates new channels for companies from different countries and regions and provides the opportunity to do business, strengthen cooperation and promote trade. Oboya's strategy is to work globally in the various markets in the cultivation and flower industry, which it's important for Oboya to participate in the major trade shows. Oboya has its own booth at the fair and will show/marketing the European cultivation products and technology to the Chinese market. The purpose of t

I vårt pressrum kan du läsa de senaste pressmeddelandena, få tillgång till pressmaterial och hitta kontaktinformation.

Besök vårt pressrum